Astrana Health, Inc.ASTH
Price (close)
$36.37
Market cap
$2.0B
P/E
50.0x
Revenue (TTM)
$3.8B
Net income
$40.5M
Dividend yield
—
1-year total return
30.5%
Net margin
1.1%
Revenue growth
58.9%
Debt / equity
1.13x
What Astrana Health, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $687.2M | $773.9M | $1.1B | $1.4B | $2.0B | $3.2B |
| Net income | $37.7M | $68.9M | $45.2M | $60.7M | $43.1M | $22.5M |
| Free cash flow | $45.0M | $51.1M | $59.2M | $39.7M | $44.2M | $104.5M |
More on ASTH.
- Astrana Health, Inc. summary
- Astrana Health, Inc. financial statements
- Astrana Health, Inc. key metrics
- Astrana Health, Inc. health scores and style box
- Astrana Health, Inc. earnings
- Astrana Health, Inc. dividends
- Astrana Health, Inc. valuation
- Astrana Health, Inc. ownership and insiders
- Astrana Health, Inc. peers
Figures from Astrana Health, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.